Amyloid receptor and calcitonin receptor dual agonists and their uses

TW202637588APending Publication Date: 2026-09-16INNOVENT BIOLOGICS (SUZHOU) CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114145949
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-11-26
Filing Date
2025-11-25
Publication Date
2026-09-16

Smart Images

  • Figure TWG2TA001076516_001
    Figure TWG2TA001076516_001
  • Figure TWG2TA001076516_002
    Figure TWG2TA001076516_002
  • Figure TWG2TA001076516_003
    Figure TWG2TA001076516_003
Patent Text Reader

Abstract

This disclosure relates to compounds that dually agonize amyloid receptors and calcitonin receptors and thus can reduce food intake, body weight, glucose, and / or triglycerides. This disclosure also includes pharmaceutical compositions containing such compounds, and uses for treating metabolic diseases and conditions such as diabetes, overweight or obesity, cardiovascular disease, nonalcoholic steatohepatitis (NASH), dyslipidemia, and cognitive impairment, such as cognitive impairment caused by Alzheimer's disease.
Need to check novelty before this filing date? Find Prior Art